“…We identify genes in active, inactive, and poised chromatin states, and we establish the propensity of genes in each state for induction or repression by ligand-activated nuclear receptors, which mediate metabolic responses to myriad steroids, drugs, and environmental chemicals (41)(42)(43). Further, we elucidate sex-differential chromatin states at sex-biased genes and sex-biased DHS, and we integrate these chromatin state data with binding site data from chromatin immunoprecipitation with high-throughput sequencing (ChIP-seq) for the GH-regulated TFs STAT5 (30), BCL6 (30), and CUX2 (34) and for the pioneer factors FOXA1 and FOXA2 (11,12), which impart male bias to hepatocellular carcinoma by facilitating androgen-mediated tumor promotion in males and estrogen-dependent resistance to tumorigenesis in females (44). Our findings reveal the importance of sex-dependent chromatin states in the control of liver gene expression.…”